Canada · Delayed Price · Currency is CAD DiagnosTear Technologies Company Description
DiagnosTear Technologies Inc., an ophthalmic company, develops and commercializes disruptive diagnostic solutions for eye diseases.
It engages in the development of TeaRx Dry Eye, a CE-IVD approved test based on the TeaRx platform for the identification and monitoring of dry eye syndrome; TeaRx Red Eye for differential assessment of adenoviral conjunctivitis, herpetic keratitis, and allergic conjunctivitis; and TeaRx Tear Collector, a non-invasive collector of one microliter of tear fluid and subsequent dilution in assay buffer for downstream analytical testing.
The company was formerly known as Oceanview Technologies Inc. and changed its name to DiagnosTear Technologies Inc. DiagnosTear Technologies Inc. was incorporated in 2023 and is based in Vancouver, Canada.
| Country | Canada |
| Founded | 2023 |
| Industry | Ophthalmic Goods |
| CEO | Shimon Gross |
Contact Details
Address: 1066 West Hastings Street Vancouver, BC V6E 3X1 Canada | |
| Phone | 972 73 2753400 |
| Website | diagnostear.com |
Stock Details
| Ticker Symbol | DTR |
| Exchange | Canadian Securities Exchange |
| Reporting Currency | CAD |
| SIC Code | 3850 |
Key Executives
| Name | Position |
|---|---|
| Shimon Gross | Chief Executive Officer |
| Yifftach Biel | Chief Financial Officer |